The Global Bioburden Testing Market is expected to be around US$ 1160.0 Million by 2025 at a CAGR of 8.5% in the given forecast period.
Bioburden is defined as the number in terms of proportion, colony or cell count of bacteria that thrive on a given unsterilized surface. Bioburden testing additionally referred to as microbial limit testing provides quantification of the bacterial cell cultures on a given unsterilized surface. The key application of bioburden testing lies in implant fixation procedures that need testing of certain tolerable bioburden limit before implantation within the physical structure.

Leave a Reply

Your email address will not be published. Required fields are marked *